Glen T. Schumock, PharmD, MBA
Associate Professor of Pharmacy Practice
Dr. Schumock has been with the Center for Pharmacoeconomic Research since its inception, and his research interests include clinical and economic outcomes evaluations of pharmaceutical products and drug classes, evaluation of progressive pharmacy services, medication safety, and assessment of medical-use policy in large provider groups and integrated delivery networks. Dr. Schumock was named a Fellow of the American College of Clinical Pharmacy in 2003 and in the same year received a certificate of appreciation from the Centers for Medicare and Medicaid Services for contributions to CMS multi-site Pharmacy Preceptorship. In 2005, Dr. Schumock received honorable mention from the American Association of Colleges of Pharmacy, Council of Faculties for the annual Innovations in Teaching Competition.
Research Interests
Dr. Schumock's research interests include clinical and economic outcomes evaluations of pharmaceuticals, evaluation of progressive pharmacy services, and assessment of medical use policy in large provider groups and integrated delivery networks.
Recent and Noteworthy Publications
Didomenico RJ, Perez A, Schumann HM, Fontana DR, Kondos GT, Schumock GT. Impact of treatment guidelines on clinical and economic outcomes of acute decompensated heart failure. Ann Pharmacother. 2008 Mar;42(3):327-33. Epub 2008 Feb 26.
Gupta SR, Wojtynek JE, Walton SM, Botticelli JT, Shields KL, Quad JE, Schumock GT. Association between hospital size and pharmacy department productivity. Am J Health Syst Pharm. 2007 May 1;64(9):937-944.
Hoffman J, Shah N, Vermeulen L, Schumock G, Grim P, Hunkler R, Hontz K. Projecting future drug expenditures – 2007. Am J Health Syst Pharm. 2008 Feb 1;65(3):234-53.
Hutchinson RA, Schumock GT. Need to develop a legal and ethical base for pharmaceutical care. Ann Pharmacother. 2007 Jul;41(7):1281-3. Epub 2007 Jul 3.
Schumock G, Arruda J, Marx S, Melnick J, Sterz R, Williams L. Pharmacoeconomic analysis of paricalcitol and calcitriol in the treatment of secondary hyperparathyroidism in haemodialysis: impact of hospitalisations and survival. J Med Econ. 2007;10:393-409.
Schumock G, Walton S, Crammer J. Net benefit analysis of divalproex sodium extended-release compared to valproic acid in the treatment of bipolar disorder. Curr Med Res Opin. 2007;23(8):1997-2004.
Schumock GT, Walton SM, Crawford S, Sarawate C. Pharmaceutical services in rural hospitals in Illinois, 2001. Am J Health Syst Pharm. 2003; 60: 666-674.
Vats V, Nutescu EA, Theobald JC, Wojtynek JE, Schumock GT. Survey of hospitals for guidelines, policies, and protocols for anticoagulants. Am J Health Syst Pharm. 2007 Jun 1;64(11):1203-8.
Walton SM, Knapp KK, Miller L, Schumock GT. Examination of state-level changes in the pharmacist labor market using Census data. J Am Pharm Assoc. 2007 May-Jun;47(3):348-57.
Honors and Awards
Best Practices in Health-System Pharmacy Management Award, American Society of Health-System Pharmacists, 2000
Fellow, American College of Clinical Pharmacy
Foundation Award for Literature Achievement in the Professional Practice of Pharmacy, American Society of Health-System Pharmacists Research and Education Foundation, 1997, for the publication of: Schumock GT, Meek PD, Ploetz PA, Vermeulen LC. Economic evaluations of clinical pharmacy services--1988-1995. The Publications Committee of the American College of Clinical Pharmacy. 1996;16(6):1188-208.
Contact Info
Department of Pharmacy Practice
University of Illinois at Chicago (MC 886)
287A College of Pharmacy
833 S. Wood St.
Chicago, IL 60612
Other Title(s)
Director of the Center for Pharmacoeconomic Research; Adjunct Professor of Pharmacy Administration
Personal Website
IHRP Affiliation(s)
Current IHRP Research Studies (PI)
Current IHRP Research Studies (Co-I)
Other Research (Non-IHRP)
Comparative Effectiveness of Anticholinergic Medications in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Recently Completed Research
Cost-effectiveness of Early Therapy with Nesiritide in Hospitalized Patients with Acute Decompensated Heart Failure: A Markov Model;
Developing Evidence-Based Research Priorities for Off-Label Drug Use;
Outcomes of Chronic Obstructive Pulmonary Disorder Management;
Prescription Drug Expenditures: Too Much Or Not Enough? A Question of Perspective;
Research on Adverse Drug Events and Reports for Oncology Drugs: The RADAR Oncology Drug Study